Coenzyme A Stock Probability of Future Stock Price Finishing Over 2.0E-4
| PPII Stock | USD 0.0002 0.00 0.00% |
Coenzyme A Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Coenzyme A for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Coenzyme A can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Coenzyme A generated a negative expected return over the last 90 days | |
| Coenzyme A has some characteristics of a very speculative penny stock | |
| Coenzyme A has high likelihood to experience some financial distress in the next 2 years | |
| Coenzyme A currently holds 419.28 K in liabilities. Coenzyme A has a current ratio of 0.16, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Coenzyme A's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 325.46 K. Net Loss for the year was (154.78 K) with profit before overhead, payroll, taxes, and interest of 228.56 K. | |
| Coenzyme A currently holds about 35.53 K in cash with (4 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.07, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Coenzyme A Technical Analysis
Coenzyme A's future price can be derived by breaking down and analyzing its technical indicators over time. Coenzyme Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Coenzyme A. In general, you should focus on analyzing Coenzyme Stock price patterns and their correlations with different microeconomic environments and drivers.
Coenzyme A Predictive Forecast Models
Coenzyme A's time-series forecasting models is one of many Coenzyme A's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Coenzyme A's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Coenzyme A
Checking the ongoing alerts about Coenzyme A for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Coenzyme A help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Coenzyme A generated a negative expected return over the last 90 days | |
| Coenzyme A has some characteristics of a very speculative penny stock | |
| Coenzyme A has high likelihood to experience some financial distress in the next 2 years | |
| Coenzyme A currently holds 419.28 K in liabilities. Coenzyme A has a current ratio of 0.16, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Coenzyme A's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 325.46 K. Net Loss for the year was (154.78 K) with profit before overhead, payroll, taxes, and interest of 228.56 K. | |
| Coenzyme A currently holds about 35.53 K in cash with (4 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.07, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Check out Coenzyme A Backtesting, Coenzyme A Valuation, Coenzyme A Correlation, Coenzyme A Hype Analysis, Coenzyme A Volatility, Coenzyme A History as well as Coenzyme A Performance. For more detail on how to invest in Coenzyme Stock please use our How to Invest in Coenzyme A guide.You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Coenzyme A. If investors know Coenzyme will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Coenzyme A listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Coenzyme A is measured differently than its book value, which is the value of Coenzyme that is recorded on the company's balance sheet. Investors also form their own opinion of Coenzyme A's value that differs from its market value or its book value, called intrinsic value, which is Coenzyme A's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Coenzyme A's market value can be influenced by many factors that don't directly affect Coenzyme A's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Coenzyme A's value and its price as these two are different measures arrived at by different means. Investors typically determine if Coenzyme A is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Coenzyme A's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.